1-9 of 9
Robert D. Schreiber
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inflammatory monocytes require type I interferon receptor signaling to activate NK cells via IL-18 during a mucosal viral infection

Amanda J. Lee, Branson Chen, Marianne V. Chew, Nicole G. Barra, Mira M. Shenouda, Tina Nham, Nico van Rooijen, Manel Jordana, Karen L. Mossman, Robert D. Schreiber, Matthias Mack, Ali A. Ashkar
Journal: Journal of Experimental Medicine
J Exp Med (2017) 214 (4): 1153–1167.
https://doi.org/10.1084/jem.20160880
Published: 06 March 2017
View articletitled, Inflammatory monocytes require type I interferon receptor signaling to activate NK cells via IL-18 during a mucosal viral infection
Open the PDF for Inflammatory monocytes require type I interferon receptor signaling to activate NK cells via IL-18 during a mucosal viral infection in another window
Journal Articles

Cancer immunoediting by the innate immune system in the absence of adaptive immunity

Timothy O’Sullivan, Robert Saddawi-Konefka, William Vermi, Catherine M. Koebel, Cora Arthur, J. Michael White, Ravi Uppaluri, Daniel M. Andrews, Shin Foong Ngiow, Michele W.L. Teng, Mark J. Smyth, Robert D. Schreiber, Jack D. Bui
Journal: Journal of Experimental Medicine
J Exp Med (2012) 209 (10): 1869–1882.
https://doi.org/10.1084/jem.20112738
Published: 27 August 2012
View articletitled, Cancer immunoediting by the innate immune system in the absence of adaptive immunity
Open the PDF for Cancer immunoediting by the innate immune system in the absence of adaptive immunity in another window
Journal Articles

Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo

Melissa Swiecki, Yaming Wang, William Vermi, Susan Gilfillan, Robert D. Schreiber, Marco Colonna
Journal: Journal of Experimental Medicine
J Exp Med (2011) 208 (12): 2367–2374.
https://doi.org/10.1084/jem.20110654
Published: 14 November 2011
View articletitled, Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo
Open the PDF for Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo in another window
Journal Articles

Type I interferon is selectively required by dendritic cells for immune rejection of tumors

Mark S. Diamond, Michelle Kinder, Hirokazu Matsushita, Mona Mashayekhi, Gavin P. Dunn, Jessica M. Archambault, Hsiaoju Lee, Cora D. Arthur, J. Michael White, Ulrich Kalinke, Kenneth M. Murphy, Robert D. Schreiber
Journal: Journal of Experimental Medicine
J Exp Med (2011) 208 (10): 1989–2003.
https://doi.org/10.1084/jem.20101158
Published: 19 September 2011
View articletitled, Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Open the PDF for Type I interferon is selectively required by dendritic cells for immune rejection of tumors in another window
Includes: Supplementary data
Journal Articles

Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells

Stephen McCartney, William Vermi, Susan Gilfillan, Marina Cella, Theresa L. Murphy, Robert D. Schreiber, Kenneth M. Murphy, Marco Colonna
Journal: Journal of Experimental Medicine
J Exp Med (2009) 206 (13): 2967–2976.
https://doi.org/10.1084/jem.20091181
Published: 07 December 2009
View articletitled, Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells
Open the PDF for Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells in another window
Includes: Supplementary data
Journal Articles

Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells

Hiroyoshi Nishikawa, Takuma Kato, Isao Tawara, Kanako Saito, Hiroaki Ikeda, Kagemasa Kuribayashi, Paul M. Allen, Robert D. Schreiber, Shimon Sakaguchi, Lloyd J. Old, Hiroshi Shiku
Journal: Journal of Experimental Medicine
J Exp Med (2005) 201 (5): 681–686.
https://doi.org/10.1084/jem.20041959
Published: 07 March 2005
View articletitled, Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells
Open the PDF for Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells in another window
Includes: Supplementary data
Journal Articles

The IκB Function of NF-κB2 p100 Controls Stimulated Osteoclastogenesis

Deborah Veis Novack, Li Yin, Amanda Hagen-Stapleton, Robert D. Schreiber, David V. Goeddel, F. Patrick Ross, Steven L. Teitelbaum
Journal: Journal of Experimental Medicine
J Exp Med (2003) 198 (5): 771–781.
https://doi.org/10.1084/jem.20030116
Published: 25 August 2003
View articletitled, The IκB Function of NF-κB2 p100 Controls Stimulated Osteoclastogenesis
Open the PDF for The IκB Function of NF-κB2 p100 Controls Stimulated Osteoclastogenesis in another window
Journal Articles

Chronic Tumor Necrosis Factor Alters T Cell Responses by Attenuating T Cell Receptor Signaling

Andrew P. Cope, Roland S. Liblau, Xiao-Dong Yang, Mauro Congia, Carlo Laudanna, Robert D. Schreiber, Lesley Probert, George Kollias, Hugh O. McDevitt
Journal: Journal of Experimental Medicine
J Exp Med (1997) 185 (9): 1573–1584.
https://doi.org/10.1084/jem.185.9.1573
Published: 05 May 1997
View articletitled, Chronic Tumor Necrosis Factor Alters T Cell Responses by Attenuating T Cell Receptor Signaling
Open the PDF for Chronic Tumor Necrosis Factor Alters T Cell Responses by Attenuating T Cell Receptor Signaling in another window
Journal Articles

FOURTH COMPONENT OF HUMAN COMPLEMENT: DESCRIPTION OF A THREE POLYPEPTIDE CHAIN STRUCTURE

Robert D. Schreiber, Hans J. Müller-Eberhard
Journal: Journal of Experimental Medicine
J Exp Med (1974) 140 (5): 1324–1335.
https://doi.org/10.1084/jem.140.5.1324
Published: 01 November 1974
View articletitled, FOURTH COMPONENT OF HUMAN COMPLEMENT: DESCRIPTION OF A THREE POLYPEPTIDE CHAIN STRUCTURE
Open the PDF for FOURTH COMPONENT OF HUMAN COMPLEMENT: DESCRIPTION OF A THREE POLYPEPTIDE CHAIN STRUCTURE in another window